MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Maria Letizia Motti, Michele Minopoli, Gioconda Di Carluccio, Paolo Antonio Ascierto, Maria Vincenza Carriero
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2020-06-01
Serie:International Journal of Molecular Sciences
Ämnen:
miRNA
melanoma
melanoma resistance to MAPK/MEK inhibitors
resistance to immune checkpoint inhibitors
Länkar:https://www.mdpi.com/1422-0067/21/12/4544
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk